Bellevue Group Ag Becton Dickinson & CO Transaction History

Bellevue Group Ag

  • $5.98 Billion
  • Q2 2024

A detailed history of Bellevue Group Ag transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bellevue Group Ag holds 347,333 shares of BDX stock, worth $83.7 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
347,333
Previous 415,700 16.45%
Holding current value
$83.7 Million
Previous $103 Million 21.09%
% of portfolio
1.36%
Previous 1.61%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$225.07 - $246.17 $15.4 Million - $16.8 Million
-68,367 Reduced 16.45%
347,333 $81.2 Million
Q1 2024

May 15, 2024
BUY
$233.45 - $247.73 $6.45 Million - $6.85 Million
27,632 Added 7.12%
415,700 $103 Million
Q4 2023

Feb 14, 2024
BUY
$232.24 - $267.23 $19.5 Million - $22.4 Million
83,838 Added 27.56%
388,068 $94.6 Million
Q3 2023

Nov 14, 2023
SELL
$254.9 - $283.59 $8.54 Million - $9.5 Million
-33,493 Reduced 9.92%
304,230 $78.7 Million
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $2.46 Million - $2.74 Million
-10,320 Reduced 2.97%
337,723 $89.2 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $3.79 Million - $4.27 Million
16,483 Added 4.97%
348,043 $86.2 Million
Q4 2022

Feb 14, 2023
SELL
$218.29 - $256.91 $715,554 - $842,150
-3,278 Reduced 0.98%
331,560 $84.3 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $415,588 - $2.15 Million
-8,144 Reduced 2.37%
334,838 $74.6 Million
Q2 2022

Aug 11, 2022
SELL
$234.74 - $275.42 $12.5 Million - $14.7 Million
-53,423 Reduced 13.48%
342,982 $84.6 Million
Q1 2022

May 13, 2022
SELL
$243.64 - $270.48 $14.4 Million - $16 Million
-59,007 Reduced 12.96%
396,405 $105 Million
Q4 2021

Feb 10, 2022
SELL
$230.08 - $250.94 $36,812 - $40,150
-160 Reduced 0.04%
455,412 $115 Million
Q3 2021

Nov 12, 2021
SELL
$232.72 - $256.47 $1.26 Million - $1.38 Million
-5,393 Reduced 1.17%
455,572 $112 Million
Q1 2021

May 12, 2021
BUY
$232.09 - $256.88 $30.9 Million - $34.2 Million
133,209 Added 40.64%
460,965 $112 Million
Q4 2020

Feb 16, 2021
BUY
$221.92 - $245.94 $14.8 Million - $16.5 Million
66,910 Added 25.65%
327,756 $82 Million
Q3 2020

Nov 16, 2020
BUY
$215.77 - $276.76 $3.22 Million - $4.13 Million
14,906 Added 6.06%
260,846 $60.7 Million
Q2 2020

Aug 13, 2020
SELL
$219.9 - $263.41 $247,167 - $296,072
-1,124 Reduced 0.45%
245,940 $58.8 Million
Q1 2020

May 14, 2020
SELL
$195.69 - $279.01 $968,274 - $1.38 Million
-4,948 Reduced 1.96%
247,064 $56.8 Million
Q4 2019

Feb 14, 2020
BUY
$236.45 - $266.82 $12.1 Million - $13.7 Million
51,185 Added 25.49%
252,012 $68.5 Million
Q3 2019

Nov 14, 2019
BUY
$230.58 - $256.08 $11.8 Million - $13.1 Million
51,135 Added 34.16%
200,827 $50.8 Million
Q2 2019

Aug 14, 2019
BUY
$217.4 - $246.08 $4.5 Million - $5.1 Million
20,720 Added 16.07%
149,692 $37.7 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $1.46 Million - $1.76 Million
7,100 Added 5.83%
128,972 $32.2 Million
Q4 2018

Feb 12, 2019
BUY
$204.73 - $257.93 $3.37 Million - $4.25 Million
16,459 Added 15.61%
121,872 $27.5 Million
Q3 2018

Nov 13, 2018
BUY
$233.07 - $256.0 $5.64 Million - $6.19 Million
24,198 Added 29.79%
105,413 $27.5 Million
Q2 2018

Aug 07, 2018
BUY
$208.1 - $233.85 $6.5 Million - $7.3 Million
31,215 Added 62.43%
81,215 $19.5 Million
Q1 2018

May 09, 2018
SELL
$205.46 - $240.27 $1.03 Million - $1.2 Million
-5,000 Reduced 9.09%
50,000 $10.8 Million
Q3 2017

Nov 13, 2017
BUY
$186.89 - $198.9 $560,670 - $596,700
3,000 Added 5.77%
55,000 $10.8 Million
Q2 2017

Aug 14, 2017
BUY
N/A
52,000
52,000 $10.1 Million

Others Institutions Holding BDX

# of Institutions
1,734
Shares Held
252M
Call Options Held
586K
Put Options Held
649K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email